Biological aspects of ceramide-enriched membrane domains - PubMed (original) (raw)
Review
. 2007 May-Jul;46(3-4):161-70.
doi: 10.1016/j.plipres.2007.03.002. Epub 2007 Mar 31.
Affiliations
- PMID: 17490747
- DOI: 10.1016/j.plipres.2007.03.002
Review
Biological aspects of ceramide-enriched membrane domains
Heike Grassmé et al. Prog Lipid Res. 2007 May-Jul.
Abstract
Ceramide has been shown to be critically involved in many aspects of cellular responses to receptor-dependent and -independent stimuli. For instance, ceramide was demonstrated to be a central component of the signaling cascades mediating apoptosis after death receptor stimulation, treatment with chemotherapy or exposure to gamma-irradiation or UV-A light. Further studies indicated the importance of ceramide for the infection of mammalian cells with bacterial, viral and parasitic pathogens. Ceramide is released by the activity of acid, neutral or alkaline sphingomyelinases or de novo synthesized. A concept unifying the diverse biological functions of ceramide indicates that ceramide forms distinct membrane domains, named ceramide-enriched membrane domains or platforms. These domains serve the clustering of receptor molecules, the re-organization of signaling proteins, the exclusion of inhibitory signals and, thus, initiate and greatly amplify a primary signal. In addition, ceramide directly interacts with and stimulates intracellular enzymes that may act together with signals initiated in ceramide-enriched membrane domains to transmit signals into a cell.
Similar articles
- Ceramide-induced cell death in malignant cells.
Carpinteiro A, Dumitru C, Schenck M, Gulbins E. Carpinteiro A, et al. Cancer Lett. 2008 Jun 8;264(1):1-10. doi: 10.1016/j.canlet.2008.02.020. Epub 2008 Mar 18. Cancer Lett. 2008. PMID: 18353542 Review. - Ceramide in bacterial infections and cystic fibrosis.
Grassmé H, Becker KA, Zhang Y, Gulbins E. Grassmé H, et al. Biol Chem. 2008 Nov;389(11):1371-9. doi: 10.1515/BC.2008.162. Biol Chem. 2008. PMID: 18783339 Review. - Ceramide: physiological and pathophysiological aspects.
Schenck M, Carpinteiro A, Grassmé H, Lang F, Gulbins E. Schenck M, et al. Arch Biochem Biophys. 2007 Jun 15;462(2):171-5. doi: 10.1016/j.abb.2007.03.031. Epub 2007 Apr 11. Arch Biochem Biophys. 2007. PMID: 17467652 Review. - Ceramide-enriched membrane domains.
Bollinger CR, Teichgräber V, Gulbins E. Bollinger CR, et al. Biochim Biophys Acta. 2005 Dec 30;1746(3):284-94. doi: 10.1016/j.bbamcr.2005.09.001. Epub 2005 Sep 26. Biochim Biophys Acta. 2005. PMID: 16226325 Review. - Ceramide-mediated clustering is required for CD95-DISC formation.
Grassmé H, Cremesti A, Kolesnick R, Gulbins E. Grassmé H, et al. Oncogene. 2003 Aug 21;22(35):5457-70. doi: 10.1038/sj.onc.1206540. Oncogene. 2003. PMID: 12934106
Cited by
- Construction of conditional acid ceramidase knockout mice and in vivo effects on oocyte development and fertility.
Eliyahu E, Shtraizent N, Shalgi R, Schuchman EH. Eliyahu E, et al. Cell Physiol Biochem. 2012;30(3):735-48. doi: 10.1159/000341453. Epub 2012 Aug 1. Cell Physiol Biochem. 2012. PMID: 22854249 Free PMC article. - An Overview of Cell Membrane Perforation and Resealing Mechanisms for Localized Drug Delivery.
He S, Singh D, Helfield B. He S, et al. Pharmaceutics. 2022 Apr 18;14(4):886. doi: 10.3390/pharmaceutics14040886. Pharmaceutics. 2022. PMID: 35456718 Free PMC article. Review. - Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization.
Ali M, Fritsch J, Zigdon H, Pewzner-Jung Y, Schütze S, Futerman AH. Ali M, et al. Cell Death Dis. 2013 Nov 21;4(11):e929. doi: 10.1038/cddis.2013.451. Cell Death Dis. 2013. PMID: 24263103 Free PMC article. - Serotonin Signaling through Lipid Membranes.
Kalinichenko LS, Kornhuber J, Sinning S, Haase J, Müller CP. Kalinichenko LS, et al. ACS Chem Neurosci. 2024 Apr 3;15(7):1298-1320. doi: 10.1021/acschemneuro.3c00823. Epub 2024 Mar 18. ACS Chem Neurosci. 2024. PMID: 38499042 Free PMC article. Review. - Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
Behl T, Kaur G, Fratila O, Buhas C, Judea-Pusta CT, Negrut N, Bustea C, Bungau S. Behl T, et al. Transl Neurodegener. 2021 Jan 15;10(1):4. doi: 10.1186/s40035-020-00226-x. Transl Neurodegener. 2021. PMID: 33446243 Free PMC article. Review.